Award recordCONTRACT

UNITED THERAPEUTICS CORP

PIID VA26117F0003· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $116,563 net obligations· UEI KK5FBFA43JS7· MD

Description

TREPROSTINIL (TYVASO) 0.6 MG/ML INHALATION SOLN REFILL KIT

First action · last action
2016-10-01 · 2020-05-21
Transactions
3
First transaction's obligation
$115,783
Base + all options value (sum of deltas)
$116,563
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40275
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$116,953$0Base award · 2016-10-01 · this action $115,783 · running total $115,783Modification P00001 · 2020-05-21 · this action $1,170 · running total $116,953Modification P00002 · 2020-05-21 · this action -$390 · running total $116,563
  • Base2016-10-01+$115,783= $115,783
  • Mod P000012020-05-21+$1,170= $116,953
  • Mod P000022020-05-21-$390= $116,563
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-10-01+$115,783$115,783TREPROSTINIL (TYVASO) 0.6 MG/ML INHALATION SOLN REFILL KIT
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-05-21+$1,170$116,953TREPROSTINIL (TYVASO) 0.6 MG/ML INHALATION SOLN REFILL KIT
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-05-21−$390$116,563TREPROSTINIL (TYVASO) 0.6 MG/ML INHALATION SOLN REFILL KIT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KK5FBFA43JS7)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0777245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,158FY2026
36C24526N0755245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0754245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24526N0723245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0722245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0707245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26117F0003_3600_V797D40275_3600 · retrieved 2026-09-26.